MeSH tree: D12.776.124.486.485.114.224.060
The herpes simplex virus type 1 (HSV-1), which affects almost two‑thirds of the world's population and is generally associated with oral herpes, may cause painful cold sores or fever blisters around the mouth.
Jul 8, 2025
0
32
The efficacy and safety of currently approved and pipeline medications for moderate-to-severe hidradenitis suppurativa (HS) are compared in a systematic literature review and network meta-analysis published online July 2 ...
Jul 7, 2025
0
16
The International Osteoporosis Foundation (IOF) Bone and Cancer Working Group has released a comprehensive review detailing the often under-recognized impact of modern anti-cancer treatments on bone health.
Jun 23, 2025
0
16
As seasons change, temperatures rise and flowers begin to bloom, many find themselves battling more than just spring fever, the feeling of excitement, restlessness or extra energy that individuals may get when spring arrives. ...
Jun 11, 2025
0
14
Increased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not respond to the latest cancer treatments, a new study shows.
Jun 10, 2025
0
18
Envision this possible future clinical scenario: a breast cancer patient and her physicians are deciding on the best possible treatment. Their decision is informed by a comprehensive molecular profile of the patient's cancer ...
Jun 5, 2025
0
32
Certain medications used in the treatment of bone conditions, particularly when combined with corticosteroids, may significantly increase the risk of a rare but serious jaw disease. This finding comes from a study by the ...
Jun 3, 2025
0
50
Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with standard chemotherapy before surgery ...
Jun 2, 2025
0
34
A study has revealed why some patients don't respond to immune checkpoint blockade (ICB) therapy for solid cancer tumors and identifies a new combination treatment.
Jun 2, 2025
0
25
In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the combination of the immunotherapy drug avelumab and targeted agent cetuximab had almost four times longer ...
Jun 1, 2025
0
30
